The third round of the Shanghai exchange of the content outflow! The relevant hot spots are reviewed one by one.

Guide: strictly guard against string marking, pay attention to the difference ratio!June 18, after the meeting of the National Joint Acquisition Office, we are highly concerned about the June 24th, the National Joint Management conference in Shanghai, what exactly talked about what contentDrug Intelligence Network the first time through the relevant channels, got the following informationconference, a total of astellas, msd, ucb, Novartis, The Drug Company's related enterprises, Yangzijiang, Huahai, Qilu, Hainan Aike, Chengdu Chijin, Stone Medicine Ohi about 12 enterprises attended the meetingis understood that the core content of the Shanghai exchange is "two undecided", "five listens" and "one exchange"two undecided, respectively, the third round of national belt procurement program site did not give a clear contentThe implementation timetable for specific country acquisitions has not been finalizedfive listens, respectively, the conference organizers put forward five aspects, listen to views, the problem of bad price comparison, the specific reporting volume and procurement cycle of the problemthe question of serial biddingfourth, the choice of antibiotic stakethe question of winning the bid at most five or moreexchange, that is, participants on this issue after the exchange, the relevant enterprises have put forward their own views and viewsabove, is the whole core content of the Shanghai conferenceCompared with the expectations of all people, there is quite a path of intangible, the higher the expectation, the loss will have a high meaningthrough the limited two undecided, five listening, one exchange, the author briefly analyzed as follows: , the report has begun, the program will not be too far According to the relevant provinces (Liaoning, Hunan and other provinces issued the relevant documents) to fill in the number of shows that the third batch of volume procurement has begun to report volume, the municipal medical and health institutions have basically started to report on June 23, 2020, the deadline is about July 3, the city audit generally time is July 3-7, 2020 Based on the previous time period, it is expected that in mid-to-late July will organize a formal interpretation of the volume procurement, about the end of July to early August to officially start the quotation work Therefore, according to this time period, the core of the formal program will not have too much adjustment, after all, the health care bureau's program, in the past three rounds of two batches on the basis of more and more rich, perfect , the difference ratio is a sensitive issue Many media charts quickly organize third-party data, but such articles can mislead the relevant readers, many enterprises more than once think that such articles may seem fancy, but the general basic difference between the calculation of errors is wrong This is in fact the national belt procurement re-emphasized a detail of the problem, the difference ratio is of great importance, often different difference coefficients directly determine the final direction of the standard, is not the theoretical addition and subtraction of the division so simple three, about the bid A string, i.e a perimeter Once upon a time, the bid in 2008 and 09 in some places in the tender procurement, very "market" But with 2015 to date, the behavior of the bid is almost sporadic, so far, few enterprises have dared to play in the context of sunshine, transparency, openness and mandatory decline However, the probability of the existence of string is not without, mainly applicable to the extreme situation of the two backgrounds: First, holding many of the same procurement varieties between different enterprises, whether there will be cross-bid But the premise of this string is how much competition the relevant varieties are If a competitor exceeds a certain number there is little possibility of a string Second, the temporary purchase of fewer varieties but the next round or the next round of varieties will meet between different enterprises, whether there will be a string of bids Again, this situation depends on the number and number of competitors involved Third, in addition to the string, but also beware of the "accompanying standard" situation four, 4 plus 7 and the expansion, only 3 injections The second round of national picks, only one, the third round of national picks, there are three, respectively, injection with aphhase, left ethyl lasitan, moxisha sodium chloride In terms of the number of varieties, not much On May 14, the State Drug Administration officially issued the "Announcement on the evaluation of the quality and efficacy of generic chemical injections", which made it clear that, in addition to sodium chloride injections, glucose injections, sodium glucose injections, injection water, and some radioactive drugs, generic chemical injections have been listed, and varieties that have not been approved in accordance with the principles consistent with the quality and efficacy of the original drug research need to be evaluated in a consistent way With the injection consistency evaluation requirements to land, the domestic injection of the band procurement is bound to accelerate the push five, up to a few winning bids From the 4 plus 7 exclusive winning bid, the joint mining expansion of the three winning bid to the second batch of 6 winning bid As can be seen, the national mining party has been adjusting the number of winning bids, now, not the number of winning bids the better on June 4, , Yunnan Medical Security Bureau issued a "Yunnan Medical Security Bureau on the submission of written information notes and capacity list of letters", the document said that in the process of monitoring the procurement of state-belt drugs, found that some selected enterprises failed to supply the selected drugs in accordance with hospital demand in a timely manner, according to which the Yunnan Provincial Medical Security Bureau asked the relevant pharmaceutical manufacturers to submit a written statement and capacity list that can not be supplied normally, and sealed the company's official seal before June 1 After verification, there is no reasonable reason, Yunnan will be in accordance with the relevant provisions of the supply of the province's medical insurance credit supervision records and report to the State Joint Management, and in accordance with the provisions of the replacement of the relevant drugs, to ensure the hospital's drug supply what is the reason why some enterprises do not supply, because it does not take into account the balance of low prices and volume, or other issues, it is not known But a lot of things are too late, the original intention of the bid area is to hope that pharmaceutical companies reasonable quotation, but in fact, in order to obtain a high-quality market, enterprises are still crazy to reduce prices, in this context, a number of successful dilution of the market, and did not achieve the original ideal effect anyway, the third batch of national belt procurement arrows in the string, had to be sent As a favorable grasping hand of drug supply guarantee, the rapid advance of national volume procurement will directly affect the structure of provincial and municipal quantity procurement varieties, as a pharmaceutical enterprise, pay attention to good, policy so, can only follow the trend .